Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.

BACKGROUND: Plasma DNA obtained from a pregnant woman contains a mixture of maternal and fetal DNA. The fetal DNA proportion in maternal plasma is relatively consistent as determined using polymorphic genetic markers across different chromosomes in euploid pregnancies. For aneuploid pregnancies, the...

Full description

Bibliographic Details
Main Authors: Gary J W Liao, K C Allen Chan, Peiyong Jiang, Hao Sun, Tak Y Leung, Rossa W K Chiu, Y M Dennis Lo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3362548?pdf=render
id doaj-a8bf6683cebb450fa60f08f14a0c9fca
record_format Article
spelling doaj-a8bf6683cebb450fa60f08f14a0c9fca2020-11-25T01:08:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3815410.1371/journal.pone.0038154Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.Gary J W LiaoK C Allen ChanPeiyong JiangHao SunTak Y LeungRossa W K ChiuY M Dennis LoBACKGROUND: Plasma DNA obtained from a pregnant woman contains a mixture of maternal and fetal DNA. The fetal DNA proportion in maternal plasma is relatively consistent as determined using polymorphic genetic markers across different chromosomes in euploid pregnancies. For aneuploid pregnancies, the observed fetal DNA proportion measured using polymorphic genetic markers for the aneuploid chromosome would be perturbed. In this study, we investigated the feasibility of analyzing single nucleotide polymorphisms using targeted massively parallel sequencing to detect such perturbations in mothers carrying trisomy 21 fetuses. METHODOLOGY/PRINCIPAL FINDINGS: DNA was extracted from plasma samples collected from fourteen pregnant women carrying singleton fetuses. Hybridization-based targeted sequencing was used to enrich 2 906 single nucleotide polymorphism loci on chr7, chr13, chr18 and chr21. Plasma DNA libraries with and without target enrichment were analyzed by massively parallel sequencing. Genomic DNA samples of both the mother and fetus for each case were genotyped by single nucleotide polymorphism microarray analysis. For the targeted regions, the mean sequencing depth of the enriched samples was 225-fold higher than that of the non-enriched samples. From the targeted sequencing data, the ratio between fetus-specific and shared alleles increased by approximately 2-fold on chr21 in the paternally-derived trisomy 21 case. In comparison, the ratio is decreased by approximately 11% on chr21 in the maternally-derived trisomy 21 cases but with much overlap with the ratio of the euploid cases. Computer simulation revealed the relationship between the fetal DNA proportion, the number of informative alleles and the depth of sequencing. CONCLUSIONS/SIGNIFICANCE: Targeted massively parallel sequencing of single nucleotide polymorphism loci in maternal plasma DNA is a potential approach for trisomy 21 detection. However, the method appears to be less robust than approaches using non-polymorphism-based counting of sequence tags in plasma.http://europepmc.org/articles/PMC3362548?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Gary J W Liao
K C Allen Chan
Peiyong Jiang
Hao Sun
Tak Y Leung
Rossa W K Chiu
Y M Dennis Lo
spellingShingle Gary J W Liao
K C Allen Chan
Peiyong Jiang
Hao Sun
Tak Y Leung
Rossa W K Chiu
Y M Dennis Lo
Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
PLoS ONE
author_facet Gary J W Liao
K C Allen Chan
Peiyong Jiang
Hao Sun
Tak Y Leung
Rossa W K Chiu
Y M Dennis Lo
author_sort Gary J W Liao
title Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
title_short Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
title_full Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
title_fullStr Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
title_full_unstemmed Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
title_sort noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma dna.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description BACKGROUND: Plasma DNA obtained from a pregnant woman contains a mixture of maternal and fetal DNA. The fetal DNA proportion in maternal plasma is relatively consistent as determined using polymorphic genetic markers across different chromosomes in euploid pregnancies. For aneuploid pregnancies, the observed fetal DNA proportion measured using polymorphic genetic markers for the aneuploid chromosome would be perturbed. In this study, we investigated the feasibility of analyzing single nucleotide polymorphisms using targeted massively parallel sequencing to detect such perturbations in mothers carrying trisomy 21 fetuses. METHODOLOGY/PRINCIPAL FINDINGS: DNA was extracted from plasma samples collected from fourteen pregnant women carrying singleton fetuses. Hybridization-based targeted sequencing was used to enrich 2 906 single nucleotide polymorphism loci on chr7, chr13, chr18 and chr21. Plasma DNA libraries with and without target enrichment were analyzed by massively parallel sequencing. Genomic DNA samples of both the mother and fetus for each case were genotyped by single nucleotide polymorphism microarray analysis. For the targeted regions, the mean sequencing depth of the enriched samples was 225-fold higher than that of the non-enriched samples. From the targeted sequencing data, the ratio between fetus-specific and shared alleles increased by approximately 2-fold on chr21 in the paternally-derived trisomy 21 case. In comparison, the ratio is decreased by approximately 11% on chr21 in the maternally-derived trisomy 21 cases but with much overlap with the ratio of the euploid cases. Computer simulation revealed the relationship between the fetal DNA proportion, the number of informative alleles and the depth of sequencing. CONCLUSIONS/SIGNIFICANCE: Targeted massively parallel sequencing of single nucleotide polymorphism loci in maternal plasma DNA is a potential approach for trisomy 21 detection. However, the method appears to be less robust than approaches using non-polymorphism-based counting of sequence tags in plasma.
url http://europepmc.org/articles/PMC3362548?pdf=render
work_keys_str_mv AT garyjwliao noninvasiveprenataldiagnosisoffetaltrisomy21byallelicratioanalysisusingtargetedmassivelyparallelsequencingofmaternalplasmadna
AT kcallenchan noninvasiveprenataldiagnosisoffetaltrisomy21byallelicratioanalysisusingtargetedmassivelyparallelsequencingofmaternalplasmadna
AT peiyongjiang noninvasiveprenataldiagnosisoffetaltrisomy21byallelicratioanalysisusingtargetedmassivelyparallelsequencingofmaternalplasmadna
AT haosun noninvasiveprenataldiagnosisoffetaltrisomy21byallelicratioanalysisusingtargetedmassivelyparallelsequencingofmaternalplasmadna
AT takyleung noninvasiveprenataldiagnosisoffetaltrisomy21byallelicratioanalysisusingtargetedmassivelyparallelsequencingofmaternalplasmadna
AT rossawkchiu noninvasiveprenataldiagnosisoffetaltrisomy21byallelicratioanalysisusingtargetedmassivelyparallelsequencingofmaternalplasmadna
AT ymdennislo noninvasiveprenataldiagnosisoffetaltrisomy21byallelicratioanalysisusingtargetedmassivelyparallelsequencingofmaternalplasmadna
_version_ 1725182992177954816